Clinical Case Reports (Jun 2021)

Transient disappearance of CD19+/CD5+ B‐lymphocyte clone in peripheral blood in a patient with CLL during SARS‐CoV‐2‐related mild disease

  • Remo Barnabei,
  • Giulio Di Michele,
  • Antonio Cellini,
  • Gianfranco Amicosante,
  • Mariagrazia Perilli,
  • Pierangelo Bellio,
  • Alessandra Piccirilli,
  • Giuseppe Celenza

DOI
https://doi.org/10.1002/ccr3.4238
Journal volume & issue
Vol. 9, no. 6
pp. n/a – n/a

Abstract

Read online

Abstract Although lymphopenia is currently considered a good predictor for the prognosis of COVID‐19, it must be critically evaluated in patients with CLL, where other clinical markers should be considered to define the prognosis and treatment.

Keywords